Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Women with PCOS in Missan Province have higher weight, hormonal imbalances, and metabolic issues.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

The circadian clock plays a key role in hair growth and its disruption can affect hair regeneration.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

A hair test shows promise for early mood disorder diagnosis.

Blood metabolites significantly influence alopecia areata risk.

PCOS diagnosis and treatment should consider race and ethnicity for accuracy.

Women with PCOS may have a higher risk of Alzheimer's disease.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Rosacea may be linked to gut and brain issues, not just a skin problem.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Severe alopecia areata may increase the risk of heart-related diseases.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Microbial imbalances in hair follicles may contribute to hair loss, especially in women.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.